Search

Your search keyword '"Laplaud, David-Axel"' showing total 29 results

Search Constraints

Start Over You searched for: Author "Laplaud, David-Axel" Remove constraint Author: "Laplaud, David-Axel" Publisher elsevier bv Remove constraint Publisher: elsevier bv
29 results on '"Laplaud, David-Axel"'

Search Results

3. Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: a retrospective observational cohort study

4. Disease modifying therapies and disease activity during pregnancy and postpartum in a contemporary cohort of relapsing Multiple Sclerosis patients

5. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial

6. Corrigendum to “Oligoclonal myelin-reactive T-cell infiltrates derived from neuromyelitis optica spectrum disorder (NMOSD) lesions are enriched in Th17 cells” [Clinical Immunology 130 (2009) 133–144]

8. Integrative molecular profiling of autoreactive CD4 T cells in autoimmune hepatitis

9. L’interféron bêta-1a sous-cutané 22/44 μg démontre une efficacité comparable à celle du tériflunomide chez les patients atteints de sclérose en plaques nouvellement traités – Étude menée avec l’Observatoire français de la sclérose en plaques (OFSEP)

10. BEST MS : étude nationale prospective comparant l’efficacité du natalizumab et du fingolimod dans les formes actives de sclérose en plaques

14. Existe-t-il un biomarqueur universel sanguin de réponse aux traitements dans la sclérose en plaques ? Étude UBITMUS (Universal BIomarker of Treatment in MS)

15. Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data

16. Human Induced Pluripotent Stem Cell-Derived Astrocytes Are Differentially Activated by Multiple Sclerosis-Associated Cytokines

17. Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data

18. An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8 + T cells involved in multiple sclerosis

19. Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data

20. Neuropathologic, phenotypic and functional analyses of Mucosal Associated Invariant T cells in Multiple Sclerosis

23. Unaltered regulatory B-cell frequency and function in patients with multiple sclerosis

29. Serial blood T cell repertoire alterations in multiple sclerosis patients; correlation with clinical and MRI parameters

Catalog

Books, media, physical & digital resources